
Mounjaro Beats Ozempic in Study
Business Wars Daily
00:00
The Results of a Study Comparing Munjaro and Ozempic for Weight Loss
Analyzing the effectiveness of Munjaro and Ozempic for weight loss, discussing Eli Lilly's new drug Zepbound and Novo Nordisk's weight loss version of Ozempic called Wegovi, and highlighting the ongoing competition between the two companies.
Transcript
Play full episode